Barclays PLC raised its holdings in The Clorox Company (NYSE:CLX – Get Rating) by 8.8% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 116,948 shares of the company’s stock after buying an additional 9,448 shares during the quarter. Barclays PLC’s holdings in Clorox were worth $15,015,000 as of its most recent SEC filing.
Several other institutional investors have also recently added to or reduced their stakes in the business. Vanguard Group Inc. lifted its stake in Clorox by 1.3% in the first quarter. Vanguard Group Inc. now owns 14,685,046 shares of the company’s stock valued at $2,041,661,000 after buying an additional 185,012 shares during the period. State Street Corp raised its position in shares of Clorox by 9.6% during the second quarter. State Street Corp now owns 8,907,083 shares of the company’s stock worth $1,255,721,000 after purchasing an additional 778,269 shares during the period. Wells Fargo & Company MN raised its position in shares of Clorox by 2.4% during the second quarter. Wells Fargo & Company MN now owns 3,557,161 shares of the company’s stock worth $501,489,000 after purchasing an additional 82,698 shares during the period. Federated Hermes Inc. raised its position in shares of Clorox by 86.2% during the second quarter. Federated Hermes Inc. now owns 1,945,898 shares of the company’s stock worth $274,332,000 after purchasing an additional 901,040 shares during the period. Finally, Northern Trust Corp raised its position in shares of Clorox by 1.1% during the first quarter. Northern Trust Corp now owns 1,931,351 shares of the company’s stock worth $268,515,000 after purchasing an additional 21,058 shares during the period. 79.12% of the stock is owned by institutional investors and hedge funds.
Clorox Stock Down 0.5 %
Shares of NYSE:CLX opened at $140.98 on Wednesday. The company has a market capitalization of $17.39 billion, a PE ratio of 43.25, a price-to-earnings-growth ratio of 2.98 and a beta of 0.31. The company has a debt-to-equity ratio of 4.99, a current ratio of 0.88 and a quick ratio of 0.50. The business has a fifty day moving average price of $145.51 and a two-hundred day moving average price of $143.11. The Clorox Company has a 1 year low of $120.50 and a 1 year high of $175.93.
Clorox Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 10th. Shareholders of record on Wednesday, January 25th will be paid a $1.18 dividend. The ex-dividend date is Tuesday, January 24th. This represents a $4.72 dividend on an annualized basis and a yield of 3.35%. Clorox’s dividend payout ratio (DPR) is presently 144.79%.
Analyst Ratings Changes
A number of equities analysts have recently weighed in on CLX shares. Deutsche Bank Aktiengesellschaft upped their target price on Clorox from $148.00 to $151.00 and gave the stock a “hold” rating in a research report on Tuesday, December 6th. UBS Group upped their target price on Clorox from $119.00 to $129.00 and gave the stock a “sell” rating in a research report on Wednesday, November 2nd. JPMorgan Chase & Co. upped their target price on Clorox from $126.00 to $135.00 and gave the stock an “underweight” rating in a research report on Friday, January 13th. DA Davidson upped their target price on Clorox from $124.00 to $155.00 and gave the stock a “neutral” rating in a research report on Wednesday, November 2nd. Finally, StockNews.com initiated coverage on Clorox in a research report on Wednesday, October 12th. They issued a “hold” rating for the company. Nine investment analysts have rated the stock with a sell rating, four have given a hold rating and one has issued a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Reduce” and a consensus price target of $136.92.
Clorox Company Profile
The Clorox Co engages in the manufacture and marketing of consumer and professional products. It operates through the following business segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment consists of cleaning products, professional products and vitamins, minerals and supplements mainly marketed and sold in the United States.
- Get a free copy of the StockNews.com research report on Clorox (CLX)
- Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
- How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
- Is the Pain Over for Baudax Bio Investors after a 70% Spike?
- Will Rocket Lab’s First U.S. Launch Send Stock Into Stratosphere?
- 3 Retail Stocks Ringing the Register in 2023
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.